Trials / Completed
CompletedNCT02611609
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Healios K.K. · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
A study to examine the safety (and potential efficacy) of the adult stem cell investigational product, MultiStem, in adults who have Acute Respiratory Distress Syndrome (ARDS). The primary hypothesis is that MultiStem will be safe in ARDS patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MultiStem | |
| BIOLOGICAL | MultiStem | |
| BIOLOGICAL | Placebo |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-09-01
- Completion
- 2019-07-01
- First posted
- 2015-11-23
- Last updated
- 2019-11-20
Locations
10 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT02611609. Inclusion in this directory is not an endorsement.